Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 108

Sort by

Sort Order Select

Journal Articles

Safety and Efficacy of Propylene Glycol-Free Melphalan (Evomela) in Patients with AL Amyloidosis Undergoing Autologous Stem Cell Transplantation: Preliminary Results of a Phase II Study

Shayna Sarosiek, John Mark Sloan, MD, Karen Quillen, MDMPH, Dina Brauneis, ANP, Ramon Cruz, Amanda Schulman, Salli Fennessey, Anthony Shelton, Vaishali Sanchorawala, MD

Blood (2019) 134 (Supplement_1): 4578.

https://doi.org/10.1182/blood-2019-129095

Published: 2019

Journal Articles

Oral Arsenic Trioxide in Front Line Therapy for Acute Promyelocytic Leukemia. A Prospective Costa Rican Study

Mariela Rodriguez, MD, Ronald Rojas, Alejandra Vargas, MD, Miguel Angel Rodriguez, MD, Claudia Garcia, MD, Juliana Esquivel, MD, Jose Gerardo Rojas, MD, Willem Bujan Boza, MD

Blood (2019) 134 (Supplement_1): 3838.

https://doi.org/10.1182/blood-2019-122627

Published: 2019

Journal Articles

Asian Subgroup Analysis - Denosumab Vs Zoledronic Acid in Bone Disease Treatment of Newly Diagnosed Multiple Myeloma: An International, Double-Blind, Double-Dummy, Randomized Controlled Phase 3 Study

Chang-Ki Min, MD PhD, Sung-Soo Yoon, MD PhD, Wee Joo Chng, MB ChB, PhD FRCP(UK), FRCPath, FAMS, Shang-Yi Huang, MD, PhD, Cheng-Shyong Chang, MD, Raymond Siu Ming Wong, Kazuyuki Shimizu, MD PhD, Nan Gao, Anthony Glennane, MD, Xuesong Guan

Blood (2018) 132 (Supplement 1): 3251.

https://doi.org/10.1182/blood-2018-99-113132

Published: 2018

Journal Articles

Carfilzomib-Associated Renal Toxicity Is Common and Unpredictable: An Analysis of 114 Patients

Blood (2018) 132 (Supplement 1): 1966.

https://doi.org/10.1182/blood-2018-99-112851

Published: 2018

Journal Articles

Overall Survival (OS) Benefit of Oral Ixazomib in Combination with Lenalidomide and Dexamethasone (IRd) Vs Lenalidomide and Dexamethasone (Rd) in Asian Patients (pts) with Relapsed and/or Refractory Multiple Myeloma (RRMM): Pooled-Analysis from the Tourmaline-MM1 and the China Continuation Studies

Blood (2018) 132 (Supplement 1): 5637.

https://doi.org/10.1182/blood-2018-99-116844

Published: 2018

Journal Articles

Efficacy of Cidofovir in Treatment of BK Virus Induced Hemorrhagic Cystitis in Post Allogeneic Hematopoietic Cell Transplant Recipients

Eric Anthony Coomes, MD, Amanda Jacques, BScPharm, RPh, ACPR, Fotios V. Michelis, MD PhD, Dennis (Dong-Hwong) Kim, MD PhD, Santhosh Thyagu, MD, Auro Viswabandya, MDMDcine,DM Clinical Hematology, Jeff H. Lipton, MD PhD, Hans A. Messner, MD PhD, Uday Deotare, MD

Blood (2017) 130 (Supplement 1): 5479.

https://doi.org/10.1182/blood.V130.Suppl_1.5479.5479

Published: 2017

Journal Articles

Real-World Data in Relapsed Refractory Myeloma Patients Treated with Carfilzomib, a Multicenter Turkish Experience

Blood (2017) 130 (Supplement 1): 5405.

https://doi.org/10.1182/blood.V130.Suppl_1.5405.5405

Published: 2017

Journal Articles

Real-World Data in Relapsed Refractory Myeloma Patients Treated with Pomalidomide, a Multicenter Turkish Experience

Guner Hayri Ozsan, MD, Omur Gokmen Sevindik, MD, Sevil Sadri, MD, Sibel Kabukcu Hacioglu, MD, Sureyya Yigit Kaya, MD, Ayfer Geduk, MD, Ali Ugur Ural, MD, Tulin F Tuglular, MD, Vildan Ozkocaman, MD, Ahmet Muzaffer Demir, MD, Yildiz Aydin, MD, Gulsum Akgun Cagliyan, MD, Ismet Aydogdu, MD, Mustafa Pehlivan, MD, Ibrahim Muaz Yaradilmis, MD, Volkan Karakus, MD, Mehmet Yilmaz, MD, Meral Beksac, MD

Blood (2017) 130 (Supplement 1): 5430.

https://doi.org/10.1182/blood.V130.Suppl_1.5430.5430

Published: 2017

Journal Articles

A Phase Ib/II Trial of Selinexor Combined with Lenalidomide and Low Dose Dexamethasone in Patients with Relapsed / Refractory Multiple Myeloma

Darrell J White, MD, Nizar J. Bahlis, MD, Christopher P. Venner, MD, Gary J Schiller, MD, Cristina J. Gasparetto, MD, Heather J. Sutherland, MD PhD FRCPC, Michael Sebag, MD PhD, Suzanne Lentzsch, MD PhD, Rami Kotb, MD, William Bensinger, MD, Brea C. Lipe, MD, Christine I Chen, MD FRCP(C), Aldo Del Col, BSPharm, MBA, Michael G. Kauffman, MD PhD, Sharon Shacham, PhD MBA, Jacqueline Jeha, Jean-Richard Saint-Martin, Jatin Shah, MD, Richard LeBlanc, MDFRCPC

Blood (2017) 130 (Supplement 1): 1861.

https://doi.org/10.1182/blood.V130.Suppl_1.1861.1861

Published: 2017

Journal Articles

Carfilzomib Is Safe and Effective in Newly Diagnosed Patients with Multiple Myeloma with Renal Involvement

Benjamin Diamond, MD, David S Jayabalan, MSc, Roger Pearse, MD PhD, Art Perry, Karen Pekle, Ruben Niesvizky, MD, Adriana C. Rossi, MDMSc

Blood (2017) 130 (Supplement 1): 3102.

https://doi.org/10.1182/blood.V130.Suppl_1.3102.3102

Published: 2017

Journal Articles

Impact of Obesity in Patients with Multiple Myeloma Receiving High-Dose Melphalan Followed By Autologous Hematopoietic Cell Transplantation

Justina Ofori Frimpong, PharmD, BCOP, Rebecca Tombleson, PharmD, BCOP, Melissa Alsina, Jamie Shapiro, PharmD, BCOP, Jongphil Kim, PhD, Binglin Yue, MS, Janelle Perkins, PharmD, BCOP, Taiga Nishihori, MD

Blood (2016) 128 (22): 4636.

https://doi.org/10.1182/blood.V128.22.4636.4636

Published: 2016

Journal Articles

Dose-Adjusted EPOCH Chemotherapy for Untreated Peripheral T-Cell Lymphomas: Multicenter Phase II Trial of West-Jhog PTCL0707

Yoshinobu Maeda, MD PhD, Hisakazu Nishimori, MD PhD, Yasushi Hiramatsu, Isao Yoshida, Masatoshi Uno, Yasufumi Masaki, MD PhD, Kazutaka Sunami, MD PhD, Taro Masunari, Yuichiro Nawa, Hiroshi Gomyo, Hiromichi Yamane, Tsutomu Takahashi, MD PhD, Tomofumi Yano, Hidetaka Takimoto, MD, Keitaro Matsuo, MD PhD, Tadashi Yoshino, MD PhD, Mitsune Tanimoto, MD PhD

Blood (2016) 128 (22): 5349.

https://doi.org/10.1182/blood.V128.22.5349.5349

Published: 2016

Journal Articles

Addition of Astatine-211-Labeled Anti-CD45 Antibody to Total Body Irradiation (TBI) As Conditioning for DLA-Identical Marrow Transplantation: A Novel Strategy to Overcome Graft Rejection in a Canine Presensitization Model

Huiying Qiu, MD, Erlinda B Santos, Rainer F. Storb, MD, Donald K Hamlin, D Scott Wilbur, PhD, Brenda M Sandmaier, MD

Blood (2016) 128 (22): 2152.

https://doi.org/10.1182/blood.V128.22.2152.2152

Published: 2016

Journal Articles

BEAM or BeEAM High-Dose Chemotherapy Followed By ASCT: A Single Center Comparative Analysis of Toxicity

Vincent Ribrag, MD, Khalil Saleh, MD, Alina Danu, MD, Serge Koscielny, Sylvain Pilorge, MD, Cristina castilla-Lorente, MD, David Ghez, Ph DMD, Julien Lazarovici, MD, Jean-Marie Michot, MD, Valerie Lapierre, PhD MD, Kamelia Alexandrova, Julia Arfi-Rouche, MD, Jean-Henri Bourhis, MD PhD

Blood (2016) 128 (22): 4648.

https://doi.org/10.1182/blood.V128.22.4648.4648

Published: 2016

Journal Articles

Cardiac and Renal Complications of Carfilzomib Therapy in Patients with Multiple Myeloma

Meletios A. Dimopoulos, Maria Roussou, Maria Gavriatopoulou, Erasmia Psimenou, Dimitrios Ziogas, Evangelos Eleutherakis-Papaiakovou, Despina Fotiou, Magdalini Migkou, Nikolaos Kanellias, Ioannis Panagiotidis, Argyrios Ntalianis, Evangelos Repasos, Elektra Papadopoulou, Kimon Stamatelopoulos, Efstathios Manios, Constantinos Pamboukas, Sofoklis Kontogiannis, Evangelos Terpos, Efstathios Kastritis, MD

Blood (2016) 128 (22): 4491.

https://doi.org/10.1182/blood.V128.22.4491.4491

Published: 2016

Journal Articles

High Incidence of HHV-6 Infection Associated with Bendamustine, Cytarabine, Etoposide and Melphalan (BeEAM) Conditioning Regimen: Results of a Monocentric and Retrospective Study

Simon Favre, Mathieu Sauvezie, Marie Sarah Dilhuydy, MD, Stéphane Vigouroux, Reza Tabrizi, Gaelle Laboure, Margot Robles, noel-Jean Milpied, MD, Krimo Bouabdallah, MD

Blood (2016) 128 (22): 5817.

https://doi.org/10.1182/blood.V128.22.5817.5817

Published: 2016

Journal Articles

Bendamustine-Based (BeEAM) Conditioning before Autologous Stem Cell Transplantation: Result of a French Multicenter Study of 386 Patients from Lysa Centers

Blood (2016) 128 (22): 3450.

https://doi.org/10.1182/blood.V128.22.3450.3450

Published: 2016

Journal Articles

Children with Thalassemia Major Display Abnormal Renal Tubular Function

Maria Paola Boaro, Giada Biddeci, Elena Varotto, Giulia Geranio, Valderza Beqiri, Giuseppe Basso, Maria Ludovica Frizziero, Enrico Vidal, Maria Caterina Putti, MD

Blood (2016) 128 (22): 3628.

https://doi.org/10.1182/blood.V128.22.3628.3628

Published: 2016

Journal Articles

Age Adjusted Telomere Length Decreases Following Treatment for Pediatric Acute Lymphoblastic Leukemia, but Does Not Predict Toxicity

Pasquale M Barbaro, MBBS FRACP FRCPA, Marion Mateos, MBBS (Hons) BSc (MD FRACP, Luciano Dalla-Pozza, MB BS FRACP, Anthea Ng, BAppSc, MSc, Glenn M Marshall, MBBS, MD FRACP, Jodie E Giles, Rosemary Sutton, Rebecca Dagg, BSc (Hons), Loretta Lau, MBBS, MMed, PhD FRACP, Hilda A Pickett, BSc (Hons) PhD, Roger R Reddel, BSc (MD MBBS PhDFRACP FAA

Blood (2015) 126 (23): 4984.

https://doi.org/10.1182/blood.V126.23.4984.4984

Published: 2015

Journal Articles

Autologous Hematopoietic Stem Cell Transplantation (AHSCT) in Severe Auto-Immune Disease Adult Patients: Analysis of Outcomes from the French Society for Bone Marrow Transplantation and Cellular Therapy (SFGMT-TC) in Light of the European Society for Blood and Marrow Transplantation (EBMT) Activity

Perrine Guillaume-Jugnot, MD, Zora Marjanovic, Myriam Labopin, MD, Louis Terriou, MD, Christophe Deligny, Bruno Lioure, MD, Thierry Martin, Veronique Leblond, MD PhD, Gregory Pugnet, Didier Blaise, Régis Peffault de Latour, MD, Ibrahim Yakoub-Agha, MD PhD, John A Snowden, MD FRCP, FRCPath, Dominique Farge, PhD MD

Blood (2015) 126 (23): 1985.

https://doi.org/10.1182/blood.V126.23.1985.1985

Published: 2015

NARROW

Safety and Efficacy of Propylene Glycol-Free Melphalan (Evomela) in Patients with AL Amyloidosis Undergoing Autologous Stem Cell Transplantation: Preliminary Results of a Phase II Study

Oral Arsenic Trioxide in Front Line Therapy for Acute Promyelocytic Leukemia. A Prospective Costa Rican Study

Asian Subgroup Analysis - Denosumab Vs Zoledronic Acid in Bone Disease Treatment of Newly Diagnosed Multiple Myeloma: An International, Double-Blind, Double-Dummy, Randomized Controlled Phase 3 Study

Carfilzomib-Associated Renal Toxicity Is Common and Unpredictable: An Analysis of 114 Patients

Overall Survival (OS) Benefit of Oral Ixazomib in Combination with Lenalidomide and Dexamethasone (IRd) Vs Lenalidomide and Dexamethasone (Rd) in Asian Patients (pts) with Relapsed and/or Refractory Multiple Myeloma (RRMM): Pooled-Analysis from the Tourmaline-MM1 and the China Continuation Studies

Efficacy of Cidofovir in Treatment of BK Virus Induced Hemorrhagic Cystitis in Post Allogeneic Hematopoietic Cell Transplant Recipients

Real-World Data in Relapsed Refractory Myeloma Patients Treated with Carfilzomib, a Multicenter Turkish Experience

Real-World Data in Relapsed Refractory Myeloma Patients Treated with Pomalidomide, a Multicenter Turkish Experience

A Phase Ib/II Trial of Selinexor Combined with Lenalidomide and Low Dose Dexamethasone in Patients with Relapsed / Refractory Multiple Myeloma

Carfilzomib Is Safe and Effective in Newly Diagnosed Patients with Multiple Myeloma with Renal Involvement

Impact of Obesity in Patients with Multiple Myeloma Receiving High-Dose Melphalan Followed By Autologous Hematopoietic Cell Transplantation

Dose-Adjusted EPOCH Chemotherapy for Untreated Peripheral T-Cell Lymphomas: Multicenter Phase II Trial of West-Jhog PTCL0707

Addition of Astatine-211-Labeled Anti-CD45 Antibody to Total Body Irradiation (TBI) As Conditioning for DLA-Identical Marrow Transplantation: A Novel Strategy to Overcome Graft Rejection in a Canine Presensitization Model

BEAM or BeEAM High-Dose Chemotherapy Followed By ASCT: A Single Center Comparative Analysis of Toxicity

Cardiac and Renal Complications of Carfilzomib Therapy in Patients with Multiple Myeloma

High Incidence of HHV-6 Infection Associated with Bendamustine, Cytarabine, Etoposide and Melphalan (BeEAM) Conditioning Regimen: Results of a Monocentric and Retrospective Study

Bendamustine-Based (BeEAM) Conditioning before Autologous Stem Cell Transplantation: Result of a French Multicenter Study of 386 Patients from Lysa Centers

Children with Thalassemia Major Display Abnormal Renal Tubular Function

Age Adjusted Telomere Length Decreases Following Treatment for Pediatric Acute Lymphoblastic Leukemia, but Does Not Predict Toxicity

Autologous Hematopoietic Stem Cell Transplantation (AHSCT) in Severe Auto-Immune Disease Adult Patients: Analysis of Outcomes from the French Society for Bone Marrow Transplantation and Cellular Therapy (SFGMT-TC) in Light of the European Society for Blood and Marrow Transplantation (EBMT) Activity

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only